← Publication index
Fluvoxamine for the early treatment of COVID-19: a meta-analysis of randomized clinical trials
CM Guo, O Harari, C Chernecki, ...
Fluvoxamine is widely prescribed as an antidepressant. Recent studies show the drug may have a clinical benefit in treating COVID-19. We aimed to perform a meta-analysis of the …
Nearby in the record
- The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID
- Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial
- Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial